Hypoglycaemia: A little known effect of Venlafaxine overdose
- 16 February 2012
- journal article
- other
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 50 (3) , 215-217
Abstract
We report the case of a 39-year-old woman who presented with serotonin syndrome and hypoglycaemia likely due to intoxication with a very high dose of venlafaxine. This case of venlafaxine-associated hypoglycaemia was treated first by glucose perfusion, but despite large doses, hypoglycaemia recurred. Blood glucose normalized after injection of octreotide, eliminating the need for hypertonic glucose. Octreotide has been shown to decrease glucose requirements and the number of hypoglycaemic episodes in patients with sulfonylurea-induced hypoglycaemia but, to our knowledge, its ability to resolve hypoglycaemic episodes due to massive venlafaxine overdose has not yet been described.Keywords
This publication has 11 references indexed in Scilit:
- Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reportsInternational Journal of Clinical Pharmacy, 2011
- Comparison of Octreotide and Standard Therapy Versus Standard Therapy Alone for the Treatment of Sulfonylurea-Induced HypoglycemiaAnnals of Emergency Medicine, 2008
- The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reportsEuropean Journal of Clinical Pharmacology, 2008
- Cytochrome P450 2D6 Genotype Variation and Venlafaxine DosageMayo Clinic Proceedings, 2007
- Severe Hypoglycemia Following Venlafaxine IntoxicationJournal of Clinical Psychopharmacology, 2007
- The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanismsExpert Opinion on Drug Safety, 2005
- Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotideCritical Care, 2005
- The relationship between central serotonergic activity and insulin sensitivity in healthy volunteersPsychoneuroendocrinology, 1999
- Isolated venlafaxine-induced serotonin syndromeThe Journal of Emergency Medicine, 1997
- Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.Gut, 1994